enGene Holdings Inc.
USD1.74
-0.04 (-2.25%)
CEO
Ronald H. W. Cooper
IPO Date
2022-02-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$1.77
Prev. Close
$1.78
Day Low
$1.71
Day High
$1.79
52W Low
$1.40
52W High
$12.25
Market Cap
$0.09B
Volume
0.94M
| 195,000 |
| $9.53 |
| 3 Feb 2026 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | A-Award | Acquired | 195,000 | $9.53 |
| 3 Feb 2026 | Daws D. Ryan | Chief Financial Officer | A-Award | Acquired | 220,000 | $9.53 |
| 3 Feb 2026 | Cooper Ronald Harold Wilfred | director, officer: CEO & President | A-Award | Acquired | 801,000 | $9.53 |
| 3 Feb 2026 | Connolly Joan | Chief Technology Officer | A-Award | Acquired | 195,000 | $9.53 |
| 3 Feb 2026 | Boyd Matthew Ross | Chief Regulatory Officer | A-Award | Acquired | 195,000 | $9.53 |
| 3 Feb 2026 | Buck Jill | Chief Development Officer | A-Award | Acquired | 195,000 | $9.53 |
| 1 Oct 2025 | Sweiti Hussein | Chief Medical Officer | A-Award | Acquired | 600,000 | $6.83 |
| 1 Oct 2025 | Sweiti Hussein | — | Disposed | 0 | $0.00 |